Ypsomed gets FDA nod for digital add-on for autoinjectors
September 4, 2025
Ypsomed announced that the FDA granted 510(k) clearance for SmartPilot, a digital connectivity add-on for its Ypsomate autoinjectors.
Ypsomed announced that the FDA granted 510(k) clearance for SmartPilot, a digital connectivity add-on for its Ypsomate autoinjectors.
Roche announced today that it received CE mark approval for its port delivery platform containing its Susvimo therapeutic.
Intense light therapy after surgery can increase a critical protein that protects heart tissue while lowering levels of troponin, a protein indicating heart damage that’s linked to higher mortality in patients undergoing non-cardiac surgery, according to a study by researchers at CU Anschutz.
The brain depends on a constant supply of oxygen, delivered through an intricate network of tiny blood vessels. Unlike other organs, it has little energy stored and is particularly sensitive to interruptions in blood flow
Philips (NYSE: PHG)+ today announced the introduction of a new telemetry platform aiming to address critical challenges in healthcare.
A Ph.D. student at the University of Bristol has developed a convenient and cost-effective wearable patch to measure subtle temperature changes across the breast, which could in future be used to detect potential abnormalities and cancerous tumors.
Using a nasal mask instead of a traditional face mask to support very premature babies at birth can significantly reduce the need for rescue breathing and escalation of care, a world-first trial led by researchers at Monash University’s School of Clinical Sciences at Monash Health, in collaboration with Hudson Institute of Medical Research and Monash Children’s Hospital (Monash Health), has shown.
Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been tested in animal models and could protect hair from falling out during chemotherapy treatment.
Available on demand, in abundance and containing multiple biomarkers, sweat is an increasingly appealing medium for monitoring health, according to researchers at Penn State. But not everyone—especially critically ill patients—can build up enough sweat to provide a robust enough sample for current analysis techniques.
Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody—overturning decades of medical misunderstanding and opening the door to more precise ways of diagnosing and treating this medical complication.